+44-3308187254
+44-3308187254
OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.
Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers
Clinical Pharmacology & Biopharmaceutics received 1089 citations as per Google Scholar report
Articles published in Clinical Pharmacology & Biopharmaceutics have been cited by esteemed scholars and scientists all around the world. Clinical Pharmacology & Biopharmaceutics has got h-index 14, which means every article in Clinical Pharmacology & Biopharmaceutics has got 14 average citations.
Following are the list of articles that have cited the articles published in Clinical Pharmacology & Biopharmaceutics.
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | |
|---|---|---|---|---|---|---|---|---|---|
Total published articles |
81 | 83 | 60 | 60 | 23 | 12 | 9 | 17 | 19 |
Research, Review articles and Editorials |
54 | 44 | 38 | 14 | 18 | 3 | 0 | 0 | 0 |
Research communications, Review communications, Editorial communications, Case reports and Commentary |
23 | 19 | 9 | 18 | 2 | 5 | 0 | 0 | 0 |
Conference proceedings |
0 | 4 | 24 | 0 | 0 | 53 | 29 | 71 | 85 |
Citations received as per Google Scholar, other indexing platforms and portals |
84 | 109 | 111 | 125 | 107 | 115 | 85 | 82 | 93 |
| Journal total citations count | 1089 |
| Journal impact factor | 1.91 |
| Journal 5 years impact factor | 3.15 |
| Journal cite score | 2.77 |
| Journal h-index | 14 |
| Journal h-index since 2019 | 11 |
 |
Kantah M, Singh B, Sweed H, Neto GB, Kumar N, Chueire FB, Marotta F, Lorenzetti A, Bellow R, Solimene U. Beneficial effect of a multifunctional polyphytocompound in experimental prostatic hyperplasia in rats. Clinical Pharmacology & Biopharmaceutics. 2017;6(2):1-7. |
| View at Publisher | View at Google Scholar | View at Indexing | |
|
Kantah M, Singh B, Sweed H, Neto GB, Kumar N, Chueire FB, Marotta F, Lorenzetti A, Bellow R, Solimene U. Beneficial effect of a multifunctional polyphytocompound in experimental prostatic hyperplasia in rats. Clinical Pharmacology & Biopharmaceutics. 2017;6(2):1-7. |
| View at Publisher | View at Google Scholar | View at Indexing | |
|
Reddy MS. Importance of bio-available calcium and other mineral to reduce the calcium deficiency symptoms, aging, and other pertinent diseases. Clinical Pharmacology & Biopharmaceutics. 2017;6(2):1-5. |
| View at Publisher | View at Google Scholar | View at Indexing | |
|
Reddy MS. Importance of bio-available calcium and other mineral to reduce the calcium deficiency symptoms, aging, and other pertinent diseases. Clinical Pharmacology & Biopharmaceutics. 2017;6(2):1-5. |
| View at Publisher | View at Google Scholar | View at Indexing | |
|
Reddy MS. Importance of bio-available calcium and other mineral to reduce the calcium deficiency symptoms, aging, and other pertinent diseases. Clinical Pharmacology & Biopharmaceutics. 2017;6(2):1-5. |
| View at Publisher | View at Google Scholar | View at Indexing | |
|
Reddy MS. Importance of bio-available calcium and other mineral to reduce the calcium deficiency symptoms, aging, and other pertinent diseases. Clinical Pharmacology & Biopharmaceutics. 2017;6(2):1-5. |
| View at Publisher | View at Google Scholar | View at Indexing | |
|
Marotta F, Marcellino M, Solimene U, Cuffari B, Yadav H, Khokhlov AN, Lorenzetti A, Mantello A, Cervi J, Catanzaro R. A 2-year double-blind RCT follow-up study with fermented papaya preparation (FPP) modulating key markers in middle-age subjects with clustered neurodegenerative disease-risk factors. Clinical pharmacology & biopharmaceutics. 2017;6. |
| View at Publisher | View at Google Scholar | View at Indexing | |
|
Marotta F, Marcellino M, Solimene U, Cuffari B, Yadav H, Khokhlov AN, Lorenzetti A, Mantello A, Cervi J, Catanzaro R. A 2-year double-blind RCT follow-up study with fermented papaya preparation (FPP) modulating key markers in middle-age subjects with clustered neurodegenerative disease-risk factors. Clinical pharmacology & biopharmaceutics. 2017;6. |
| View at Publisher | View at Google Scholar | View at Indexing | |
|
Marotta F, Marcellino M, Solimene U, Cuffari B, Yadav H, Khokhlov AN, Lorenzetti A, Mantello A, Cervi J, Catanzaro R. A 2-year double-blind RCT follow-up study with fermented papaya preparation (FPP) modulating key markers in middle-age subjects with clustered neurodegenerative disease-risk factors. Clinical pharmacology & biopharmaceutics. 2017;6. |
| View at Publisher | View at Google Scholar | View at Indexing | |
|
Marotta F, Marcellino M, Solimene U, Cuffari B, Yadav H, Khokhlov AN, Lorenzetti A, Mantello A, Cervi J, Catanzaro R. A 2-year double-blind RCT follow-up study with fermented papaya preparation (FPP) modulating key markers in middle-age subjects with clustered neurodegenerative disease-risk factors. Clinical pharmacology & biopharmaceutics. 2017;6. |
| View at Publisher | View at Google Scholar | View at Indexing | |
|
Marotta F, Marcellino M, Solimene U, Cuffari B, Yadav H, Khokhlov AN, Lorenzetti A, Mantello A, Cervi J, Catanzaro R. A 2-year double-blind RCT follow-up study with fermented papaya preparation (FPP) modulating key markers in middle-age subjects with clustered neurodegenerative disease-risk factors. Clinical pharmacology & biopharmaceutics. 2017;6. |
| View at Publisher | View at Google Scholar | View at Indexing | |
|
Kamel MM, El-Farouk LO, Osman AS, Khorshid OA, Shabrawy-Abdo ME. Comparative study of the protective effect of metformin and sitagliptin against doxorubicin-induced cardiotoxicity in rats. Clinical Pharmacology and Biopharmaceutics. 2017;6:174. |
| View at Publisher | View at Google Scholar | View at Indexing | |
|
Kamel MM, El-Farouk LO, Osman AS, Khorshid OA, Shabrawy-Abdo ME. Comparative study of the protective effect of metformin and sitagliptin against doxorubicin-induced cardiotoxicity in rats. Clinical Pharmacology and Biopharmaceutics. 2017;6:174. |
| View at Publisher | View at Google Scholar | View at Indexing | |
|
Kamel MM, El-Farouk LO, Osman AS, Khorshid OA, Shabrawy-Abdo ME. Comparative study of the protective effect of metformin and sitagliptin against doxorubicin-induced cardiotoxicity in rats. Clinical Pharmacology and Biopharmaceutics. 2017;6:174. |
| View at Publisher | View at Google Scholar | View at Indexing | |
|
Kamel MM, El-Farouk LO, Osman AS, Khorshid OA, Shabrawy-Abdo ME. Comparative study of the protective effect of metformin and sitagliptin against doxorubicin-induced cardiotoxicity in rats. Clinical Pharmacology and Biopharmaceutics. 2017;6:174. |
| View at Publisher | View at Google Scholar | View at Indexing | |
|
Kamel MM, El-Farouk LO, Osman AS, Khorshid OA, Shabrawy-Abdo ME. Comparative study of the protective effect of metformin and sitagliptin against doxorubicin-induced cardiotoxicity in rats. Clinical Pharmacology and Biopharmaceutics. 2017;6:174. |
| View at Publisher | View at Google Scholar | View at Indexing | |
|
Kamel MM, El-Farouk LO, Osman AS, Khorshid OA, Shabrawy-Abdo ME. Comparative study of the protective effect of metformin and sitagliptin against doxorubicin-induced cardiotoxicity in rats. Clinical Pharmacology and Biopharmaceutics. 2017;6:174. |
| View at Publisher | View at Google Scholar | View at Indexing | |
|
Tangudu NK, Vujic Spasic M. Heme activates macrophage hepcidin expression via toll like receptor 4 and extracellular signal-regulated kinases signaling pathway. Clin Pharmacol Biopharm. 2017;6(166):2. |
| View at Publisher | View at Google Scholar | View at Indexing | |
|
Tangudu NK, Vujic Spasic M. Heme activates macrophage hepcidin expression via toll like receptor 4 and extracellular signal-regulated kinases signaling pathway. Clin Pharmacol Biopharm. 2017;6(166):2. |
| View at Publisher | View at Google Scholar | View at Indexing | |
|
Tangudu NK, Vujic Spasic M. Heme activates macrophage hepcidin expression via toll like receptor 4 and extracellular signal-regulated kinases signaling pathway. Clin Pharmacol Biopharm. 2017;6(166):2. |
| View at Publisher | View at Google Scholar | View at Indexing | |
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
